YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Vioxx

FDA Introduces New Conflict of Interest Rules

Aug 6, 2008 | Parker Waichman Alonso LLP
The Food & Drug Administration (FDA) has finally taken steps to address potential conflicts of interests among members of its advisory panels....

Merck's Vioxx Payouts to Begin in August

Jul 18, 2008 | Parker Waichman Alonso LLP
New Jersey-based Merck & Company will begin funding $4.85 billion to resolve state and federal claims over its painkiller Vioxx.  The first...

Drug Makers Decry FDA Safety Push

Jul 1, 2008 | Parker Waichman Alonso LLP
Drug makers are complaining that the Food & Drug Administration (FDA) is too focused on, of all things, safety.  The pharmaceutical industry...

Vioxx Settlement Deadlines Loom

Jun 30, 2008 | Parker Waichman Alonso LLP
A little over 59,000 people have registered for the Vioxx settlement, and plaintiffs who submitted paperwork early could start seeing initial...

Merck Gets Another Vioxx Win

Jun 6, 2008 | Parker Waichman Alonso LLP
Merck & Co. was on the winning end of another Vioxx court decision this week, the third favorable ruling involving the deadly painkiller in the...

Merck Gets Two Vioxx Victories, But Settlement Still on Track

May 30, 2008 | Parker Waichman Alonso LLP
Vioxx maker Merck & Co. won two court victories this week, in Texas and New Jersey, as appeals courts reversed rulings in Vioxx lawsuits. ...

Merck To Pay $58 Million in Vioxx Settlement

May 21, 2008 | Parker Waichman Alonso LLP
Drug maker Merck & Co. Inc., will pay $58 million to Massachusetts, 28 other states, and the District of Columbia, to settle lawsuits that claim...

Pfizer Negotiating Celebrex, Bextra Settlements

May 5, 2008 | Parker Waichman Alonso LLP
Celebrex and Bextra maker Pfizer Inc. has begun to settle injury claims against the painkillers.  It is estimated that between 7,000 and 9,000...

Merck Extends Another Vioxx Settlement Deadline

May 5, 2008 | Parker Waichman Alonso LLP
Merck just extended the deadline for registered participants to submit paperwork to June 30 on the Vioxx program. Merck states that the proposed...

Merck Vioxx Study Scandal Fans Opposition to Proposed FDA Rule Changes

Apr 21, 2008 | Parker Waichman Alonso LLP
Last week's revelation that Merck Inc. manipulated two Vioxx studies in order to downplay death rates has prompted more criticism of a Food &...

Page 3/35 [first] [prev] 1 2 3 4 5 6 7 8 9 10 ... [next] [last]

Vioxx
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

What condition was this medication prescribed to treat?

What dosage were you prescribed daily?

Have any of the following side effects occurred? (Please check all that apply.)






Please further describe side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News